APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Hyaluronic Acid and Botulinum Toxin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Injectable Hyaluronic Acid and Botulinum Toxin Market Analysis and Forecast 2026-2032

21 December 2025214 pages

Choose your research edition.

Industry ResearchInjectable Hyaluronic Acid and Botulinum Toxin Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Hyaluronic Acid and Botulinum Toxin Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Injectable Hyaluronic Acid and Botulinum Toxin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin include Haohai Biological, AbbVie, US World Meds, Teoxane, Suneva Medical, Sinclair, SciVision Biotech, Prollenium and Merz, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Injectable Hyaluronic Acid and Botulinum Toxin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Injectable Hyaluronic Acid and Botulinum Toxin, also provides the sales of main regions and countries. Of the upcoming market potential for Injectable Hyaluronic Acid and Botulinum Toxin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injectable Hyaluronic Acid and Botulinum Toxin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injectable Hyaluronic Acid and Botulinum Toxin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Injectable Hyaluronic Acid and Botulinum Toxin sales, projected growth trends, production technology, application and end-user industry.

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Company

Haohai Biological

AbbVie

US World Meds

Teoxane

Suneva Medical

Sinclair

SciVision Biotech

Prollenium

Merz

Medytox

LIBP

LG Life Sciences

JETEMA

Ipsen

Hugel

Galderma

Elravie (Humedix)

Daewoong

Croma-Pharma

Cleviel (Pharma Research Products)

CG Bio

Caregen

Bohus BioTech

Bloomage Bio

Beijing IMEIK

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Type

Injectable Hyaluronic Acid

Botulinum Toxin

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Application

Cosmetic

Medical

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Hyaluronic Acid and Botulinum Toxin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Hyaluronic Acid and Botulinum Toxin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Hyaluronic Acid and Botulinum Toxin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Injectable Hyaluronic Acid and Botulinum Toxin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Injectable Hyaluronic Acid and Botulinum Toxin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Hyaluronic Acid and Botulinum Toxin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injectable Hyaluronic Acid Major Manufacturers Table 3. Botulinum Toxin Major Manufacturers Table 4. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cosmetic Major Manufacturers Table 6. Medical Major Manufacturers Table 7. Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends Table 8. Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers Table 9. Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges Table 10. Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints Table 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2021-2026) Table 15. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2027-2032) Table 16. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026) & (k units) Table 18. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2027-2032) & (k units) Table 19. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2021-2026) Table 20. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2027-2032) Table 21. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Manufacturers (2021-2026) Table 25. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers, Product Type & Application Table 29. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Injectable Hyaluronic Acid and Botulinum Toxin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2021-2026) Table 36. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2027-2032) Table 37. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 39. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 40. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2021-2026) Table 41. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2027-2032) Table 42. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2026) & (US$/unit) Table 43. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2027-2032) & (US$/unit) Table 44. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2021-2026) Table 48. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2027-2032) Table 49. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 51. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 52. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2021-2026) Table 53. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2027-2032) Table 54. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2026) & (US$/unit) Table 55. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2027-2032) & (US$/unit) Table 56. Haohai Biological Company Information Table 57. Haohai Biological Business Overview Table 58. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 60. Haohai Biological Recent Development Table 61. AbbVie Company Information Table 62. AbbVie Business Overview Table 63. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 65. AbbVie Recent Development Table 66. US World Meds Company Information Table 67. US World Meds Business Overview Table 68. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 70. US World Meds Recent Development Table 71. Teoxane Company Information Table 72. Teoxane Business Overview Table 73. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 75. Teoxane Recent Development Table 76. Suneva Medical Company Information Table 77. Suneva Medical Business Overview Table 78. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 80. Suneva Medical Recent Development Table 81. Sinclair Company Information Table 82. Sinclair Business Overview Table 83. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 85. Sinclair Recent Development Table 86. SciVision Biotech Company Information Table 87. SciVision Biotech Business Overview Table 88. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 90. SciVision Biotech Recent Development Table 91. Prollenium Company Information Table 92. Prollenium Business Overview Table 93. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 95. Prollenium Recent Development Table 96. Merz Company Information Table 97. Merz Business Overview Table 98. Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 100. Merz Recent Development Table 101. Medytox Company Information Table 102. Medytox Business Overview Table 103. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 105. Medytox Recent Development Table 106. LIBP Company Information Table 107. LIBP Business Overview Table 108. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 110. LIBP Recent Development Table 111. LG Life Sciences Company Information Table 112. LG Life Sciences Business Overview Table 113. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 115. LG Life Sciences Recent Development Table 116. JETEMA Company Information Table 117. JETEMA Business Overview Table 118. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 120. JETEMA Recent Development Table 121. Ipsen Company Information Table 122. Ipsen Business Overview Table 123. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 125. Ipsen Recent Development Table 126. Hugel Company Information Table 127. Hugel Business Overview Table 128. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 130. Hugel Recent Development Table 131. Galderma Company Information Table 132. Galderma Business Overview Table 133. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 135. Galderma Recent Development Table 136. Elravie (Humedix) Company Information Table 137. Elravie (Humedix) Business Overview Table 138. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 140. Elravie (Humedix) Recent Development Table 141. Daewoong Company Information Table 142. Daewoong Business Overview Table 143. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 145. Daewoong Recent Development Table 146. Croma-Pharma Company Information Table 147. Croma-Pharma Business Overview Table 148. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 150. Croma-Pharma Recent Development Table 151. Cleviel (Pharma Research Products) Company Information Table 152. Cleviel (Pharma Research Products) Business Overview Table 153. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 155. Cleviel (Pharma Research Products) Recent Development Table 156. CG Bio Company Information Table 157. CG Bio Business Overview Table 158. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 160. CG Bio Recent Development Table 161. Caregen Company Information Table 162. Caregen Business Overview Table 163. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 165. Caregen Recent Development Table 166. Bohus BioTech Company Information Table 167. Bohus BioTech Business Overview Table 168. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 170. Bohus BioTech Recent Development Table 171. Bloomage Bio Company Information Table 172. Bloomage Bio Business Overview Table 173. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 175. Bloomage Bio Recent Development Table 176. Beijing IMEIK Company Information Table 177. Beijing IMEIK Business Overview Table 178. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 180. Beijing IMEIK Recent Development Table 181. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 182. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 183. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 184. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 185. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2021-2026) & (US$/unit) Table 186. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2027-2032) & (US$/unit) Table 187. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 188. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 189. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 190. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 191. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2021-2026) & (US$/unit) Table 192. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2027-2032) & (US$/unit) Table 193. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 198. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 199. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2021-2026) & (US$/unit) Table 200. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2027-2032) & (US$/unit) Table 201. United States Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 202. Canada Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 203. Mexico Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 204. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 205. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 206. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 207. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 208. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2021-2026) & (US$/unit) Table 209. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2027-2032) & (US$/unit) Table 210. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 211. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 212. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 213. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 214. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2021-2026) & (US$/unit) Table 215. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2027-2032) & (US$/unit) Table 216. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 220. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 221. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 222. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2021-2026) & (US$/unit) Table 223. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2027-2032) & (US$/unit) Table 224. Germany Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 225. France Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 226. U.K. Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 227. Italy Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 228. Russia Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 229. Spain Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 230. Netherlands Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 231. Switzerland Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 232. Sweden Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 233. Poland Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 234. China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 235. China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 236. China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 237. China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 238. China Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2021-2026) & (US$/unit) Table 239. China Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2027-2032) & (US$/unit) Table 240. China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 241. China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 242. China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 243. China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 244. China Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2021-2026) & (US$/unit) Table 245. China Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2027-2032) & (US$/unit) Table 246. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 247. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 248. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 249. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 250. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2021-2026) & (US$/unit) Table 251. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2027-2032) & (US$/unit) Table 252. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 253. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 254. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 255. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 256. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2021-2026) & (US$/unit) Table 257. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2027-2032) & (US$/unit) Table 258. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 260. Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 261. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 262. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 263. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 264. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2021-2026) & (US$/unit) Table 265. Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2027-2032) & (US$/unit) Table 266. Japan Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 267. South Korea Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 268. India Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 269. Australia Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 270. Taiwan Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 271. Southeast Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 272. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (US$ Million) Table 273. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (US$ Million) Table 274. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 275. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 276. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2021-2026) & (US$/unit) Table 277. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Type (2027-2032) & (US$/unit) Table 278. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (US$ Million) Table 279. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (US$ Million) Table 280. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 281. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 282. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2021-2026) & (US$/unit) Table 283. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Application (2027-2032) & (US$/unit) Table 284. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 285. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 286. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 287. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 288. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 289. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 290. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2021-2026) & (US$/unit) Table 291. SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Country (2027-2032) & (US$/unit) Table 292. Brazil Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 293. Argentina Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 294. Chile Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 295. Colombia Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 296. Peru Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 297. Saudi Arabia Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 298. Israel Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 299. UAE Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 300. Turkey Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 301. Iran Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 302. Egypt Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Table 303. Key Raw Materials Table 304. Raw Materials Key Suppliers Table 305. Injectable Hyaluronic Acid and Botulinum Toxin Distributors List Table 306. Injectable Hyaluronic Acid and Botulinum Toxin Customers List Table 307. Research Programs/Design for This Report Table 308. Authors List of This Report Table 309. Secondary Sources Table 310. Primary Sources List of Figures Figure 1. Injectable Hyaluronic Acid and Botulinum Toxin Image Figure 2. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injectable Hyaluronic Acid Image Figure 5. Botulinum Toxin Image Figure 6. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cosmetic Image Figure 9. Medical Image Figure 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Figure 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2021-2032) Figure 15. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (2021-2032) & (k units) Figure 16. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Injectable Hyaluronic Acid and Botulinum Toxin Sales YoY (2021-2032) & (k units) Figure 19. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales YoY (2021-2032) & (k units) Figure 20. China Injectable Hyaluronic Acid and Botulinum Toxin Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Injectable Hyaluronic Acid and Botulinum Toxin Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales YoY (2021-2032) & (k units) Figure 23. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Sales S

Scope & coverage.

Types
  • Injectable Hyaluronic Acid
  • Botulinum Toxin
Applications
  • Cosmetic
  • Medical
Companies covered
  • Haohai Biological
  • AbbVie
  • US World Meds
  • Teoxane
  • Suneva Medical
  • Sinclair
  • SciVision Biotech
  • Prollenium
  • Merz
  • Medytox
  • LIBP
  • LG Life Sciences
  • JETEMA
  • Ipsen
  • Hugel
  • Galderma
  • Elravie (Humedix)
  • Daewoong
  • Croma-Pharma
  • Cleviel (Pharma Research Products)
  • CG Bio
  • Caregen
  • Bohus BioTech
  • Bloomage Bio
  • Beijing IMEIK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Injectable Hyaluronic Acid and Botulinum Toxin Market by Type
  3. 1.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injectable Hyaluronic Acid
  5. 1.2.3 Botulinum Toxin
  6. 1.3 Injectable Hyaluronic Acid and Botulinum Toxin Market by Application
  7. 1.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cosmetic
  9. 1.3.3 Medical
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Injectable Hyaluronic Acid and Botulinum Toxin Market Dynamics
  1. 2.1 Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends
  2. 2.2 Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers
  3. 2.3 Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges
  4. 2.4 Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region
  3. 3.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2021-2026)
  5. 3.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2027-2032)
  6. 3.2.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region
  9. 3.4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026)
  11. 3.4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2027-2032)
  12. 3.4.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Manufacturers
  2. 4.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Manufacturers
  6. 4.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers, Product Type & Application
  13. 4.7 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market CR5 and HHI
  16. 4.8.2 2025 Injectable Hyaluronic Acid and Botulinum Toxin Tier 1, Tier 2, and Tier 3
5 Injectable Hyaluronic Acid and Botulinum Toxin Market by Type
  1. 5.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type
  2. 5.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type
  6. 5.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type
6 Injectable Hyaluronic Acid and Botulinum Toxin Market by Application
  1. 6.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application
  2. 6.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application
  6. 6.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application
7 Company Profiles
  1. 7.1 Haohai Biological
  2. 7.1.1 Haohai Biological Company Information
  3. 7.1.2 Haohai Biological Business Overview
  4. 7.1.3 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  6. 7.1.5 Haohai Biological Recent Developments
  7. 7.2 AbbVie
  8. 7.2.1 AbbVie Company Information
  9. 7.2.2 AbbVie Business Overview
  10. 7.2.3 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  12. 7.2.5 AbbVie Recent Developments
  13. 7.3 US World Meds
  14. 7.3.1 US World Meds Company Information
  15. 7.3.2 US World Meds Business Overview
  16. 7.3.3 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  18. 7.3.5 US World Meds Recent Developments
  19. 7.4 Teoxane
  20. 7.4.1 Teoxane Company Information
  21. 7.4.2 Teoxane Business Overview
  22. 7.4.3 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  24. 7.4.5 Teoxane Recent Developments
  25. 7.5 Suneva Medical
  26. 7.5.1 Suneva Medical Company Information
  27. 7.5.2 Suneva Medical Business Overview
  28. 7.5.3 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  30. 7.5.5 Suneva Medical Recent Developments
  31. 7.6 Sinclair
  32. 7.6.1 Sinclair Company Information
  33. 7.6.2 Sinclair Business Overview
  34. 7.6.3 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  36. 7.6.5 Sinclair Recent Developments
  37. 7.7 SciVision Biotech
  38. 7.7.1 SciVision Biotech Company Information
  39. 7.7.2 SciVision Biotech Business Overview
  40. 7.7.3 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  42. 7.7.5 SciVision Biotech Recent Developments
  43. 7.8 Prollenium
  44. 7.8.1 Prollenium Company Information
  45. 7.8.2 Prollenium Business Overview
  46. 7.8.3 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  48. 7.8.5 Prollenium Recent Developments
  49. 7.9 Merz
  50. 7.9.1 Merz Company Information
  51. 7.9.2 Merz Business Overview
  52. 7.9.3 Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  54. 7.9.5 Merz Recent Developments
  55. 7.10 Medytox
  56. 7.10.1 Medytox Company Information
  57. 7.10.2 Medytox Business Overview
  58. 7.10.3 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  60. 7.10.5 Medytox Recent Developments
  61. 7.11 LIBP
  62. 7.11.1 LIBP Company Information
  63. 7.11.2 LIBP Business Overview
  64. 7.11.3 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  66. 7.11.5 LIBP Recent Developments
  67. 7.12 LG Life Sciences
  68. 7.12.1 LG Life Sciences Company Information
  69. 7.12.2 LG Life Sciences Business Overview
  70. 7.12.3 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  72. 7.12.5 LG Life Sciences Recent Developments
  73. 7.13 JETEMA
  74. 7.13.1 JETEMA Company Information
  75. 7.13.2 JETEMA Business Overview
  76. 7.13.3 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  78. 7.13.5 JETEMA Recent Developments
  79. 7.14 Ipsen
  80. 7.14.1 Ipsen Company Information
  81. 7.14.2 Ipsen Business Overview
  82. 7.14.3 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  84. 7.14.5 Ipsen Recent Developments
  85. 7.15 Hugel
  86. 7.15.1 Hugel Company Information
  87. 7.15.2 Hugel Business Overview
  88. 7.15.3 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  90. 7.15.5 Hugel Recent Developments
  91. 7.16 Galderma
  92. 7.16.1 Galderma Company Information
  93. 7.16.2 Galderma Business Overview
  94. 7.16.3 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  96. 7.16.5 Galderma Recent Developments
  97. 7.17 Elravie (Humedix)
  98. 7.17.1 Elravie (Humedix) Company Information
  99. 7.17.2 Elravie (Humedix) Business Overview
  100. 7.17.3 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  102. 7.17.5 Elravie (Humedix) Recent Developments
  103. 7.18 Daewoong
  104. 7.18.1 Daewoong Company Information
  105. 7.18.2 Daewoong Business Overview
  106. 7.18.3 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  108. 7.18.5 Daewoong Recent Developments
  109. 7.19 Croma-Pharma
  110. 7.19.1 Croma-Pharma Company Information
  111. 7.19.2 Croma-Pharma Business Overview
  112. 7.19.3 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  114. 7.19.5 Croma-Pharma Recent Developments
  115. 7.20 Cleviel (Pharma Research Products)
  116. 7.20.1 Cleviel (Pharma Research Products) Company Information
  117. 7.20.2 Cleviel (Pharma Research Products) Business Overview
  118. 7.20.3 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  120. 7.20.5 Cleviel (Pharma Research Products) Recent Developments
  121. 7.21 CG Bio
  122. 7.21.1 CG Bio Company Information
  123. 7.21.2 CG Bio Business Overview
  124. 7.21.3 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  126. 7.21.5 CG Bio Recent Developments
  127. 7.22 Caregen
  128. 7.22.1 Caregen Company Information
  129. 7.22.2 Caregen Business Overview
  130. 7.22.3 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  132. 7.22.5 Caregen Recent Developments
  133. 7.23 Bohus BioTech
  134. 7.23.1 Bohus BioTech Company Information
  135. 7.23.2 Bohus BioTech Business Overview
  136. 7.23.3 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  138. 7.23.5 Bohus BioTech Recent Developments
  139. 7.24 Bloomage Bio
  140. 7.24.1 Bloomage Bio Company Information
  141. 7.24.2 Bloomage Bio Business Overview
  142. 7.24.3 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  144. 7.24.5 Bloomage Bio Recent Developments
  145. 7.25 Beijing IMEIK
  146. 7.25.1 Beijing IMEIK Company Information
  147. 7.25.2 Beijing IMEIK Business Overview
  148. 7.25.3 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  150. 7.25.5 Beijing IMEIK Recent Developments
8 North America
  1. 8.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  2. 8.1.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  3. 8.1.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  4. 8.1.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2032)
  5. 8.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  6. 8.2.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  7. 8.2.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  8. 8.2.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2032)
  9. 8.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  10. 8.3.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  2. 9.1.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  4. 9.1.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2032)
  5. 9.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  6. 9.2.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  8. 9.2.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2032)
  9. 9.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  10. 9.3.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  2. 10.1.1 China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  3. 10.1.2 China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  4. 10.1.3 China Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2032)
  5. 10.2 China Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  6. 10.2.1 China Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  7. 10.2.2 China Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  8. 10.2.3 China Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  2. 11.1.1 Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  4. 11.1.3 Asia Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2032)
  5. 11.2 Asia Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  6. 11.2.1 Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  8. 11.2.3 Asia Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2032)
  9. 11.3 Asia Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  10. 11.3.1 Asia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Injectable Hyaluronic Acid and Botulinum Toxin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  2. 12.1.1 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2032)
  5. 12.2 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  6. 12.2.1 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2032)
  9. 12.3 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  10. 12.3.1 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Injectable Hyaluronic Acid and Botulinum Toxin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Injectable Hyaluronic Acid and Botulinum Toxin Value Chain Analysis
  2. 13.1.1 Injectable Hyaluronic Acid and Botulinum Toxin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process
  6. 13.2 Injectable Hyaluronic Acid and Botulinum Toxin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Injectable Hyaluronic Acid and Botulinum Toxin Distributors
  9. 13.2.3 Injectable Hyaluronic Acid and Botulinum Toxin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst